This site is intended for healthcare professionals only
LoginRegister
Biotechnology to Drive Indias Next Industrial Revolution: Dr. Jitendra SinghBiotechnology to Drive India's Next Industrial Revolution: Dr. Jitendra Singh
Declare Cancer a Notifiable Disease, Bring Cancer Drugs Under Price Control: Parliamentary PanelAnti cancer medicines now under Schedule H2 of Drugs Rules, Here is what it means
ZydusZydus receives USFDA nod for Paliperidone ER Tablets, 1.5 mg, 3 mg, 6 mg, and 9 mg
Shilpa Biologicals, Stein Cares Ink Exclusive Biosimilar Licensing Pact for Latin AmericaAlkem Labs inks pact with Sonnet BioTherapeutics to develop, commercialise drug candidate for...
Amazon Only a Platform, Not Seller of Abortion Pills: Court Quashes Notice Against DirectorsSoon, harsher penalties for submitting false data for drug approval
Medicines worth Rs 6,975 crore in MRP terms sold through JAKs in last 10 yearsAre certain Hair Loss drugs causing suicidal thoughts? EU drugs regulator begins review
Novartis AG to Exit India Arm in Rs 1,446 Cr Deal, ChrysCapital-Led Consortium Buys 70.68% StakeSwitzerland COMCO competition commission terminates Novartis probe without consequences
Govt extends deadline for submitting applications under PLI SchemeAkums unveils Dual-Action Heartburn Relief Chewable Tablets for India
EU gives marketing authorization for Novavax updated 2024-2025 Nuvaxovid COVID vaccineEU gives marketing authorization for Novavax updated 2024-2025 Nuvaxovid COVID vaccine
GSK agrees to pay up to $2.2 bln to settle about 80000 Zantac lawsuitsGSK agrees to pay up to $2.2 bln to settle about 80000 Zantac lawsuits
Windlas Biotech Gets SEC Nod to Manufacture Dapagliflozin-Pioglitazone FDCBisoprolol, Telmisartan, Chlorthalidone FDC: CDSCO asks Windlas Biotech to submit new BE protocol
Govt Amends UCPMP 2024: CEOs Must Disclose Marketing Expenses, Free Sample Pricing Norms FinalizedPharma-sponsored Indian CMEs allowed, but Govt sets speaker-to-participant ratios for such events
X